Elion Therapeutics
The startup provides clinical research and development services focused on enhancing Amphotericin B to treat systemic and life-threatening fungal infections. Their approach enables the delivery of a broad spectrum of non-toxic antifungal drugs, improving patient safety and treatment efficacy.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$111MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup provides clinical research and development services focused on enhancing Amphotericin B to treat systemic and life-threatening fungal infections. Their approach enables the delivery of a broad spectrum of non-toxic antifungal drugs, improving patient safety and treatment efficacy.